These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
495 related articles for article (PubMed ID: 28790925)
1. NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy. Luo B; Huang F; Liu Y; Liang Y; Wei Z; Ke H; Zeng Z; Huang W; He Y Front Physiol; 2017; 8():519. PubMed ID: 28790925 [TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031 [TBL] [Abstract][Full Text] [Related]
3. Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome. Peng M; Liu Y; Xu Y; Li L; Li Y; Yang H Cell Cycle; 2021 Nov; 20(21):2278-2290. PubMed ID: 34585633 [TBL] [Abstract][Full Text] [Related]
4. Attenuation of ROS/Chloride Efflux-Mediated NLRP3 Inflammasome Activation Contributes to Alleviation of Diabetic Cardiomyopathy in Rats after Sleeve Gastrectomy. Li S; Dong S; Shi B; Xu Q; Li L; Wang S; Zhang W; Zhong M; Zhu J; Cheng Y; Zhang G; Hu S Oxid Med Cell Longev; 2022; 2022():4608914. PubMed ID: 35498125 [TBL] [Abstract][Full Text] [Related]
5. NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy. Zhang L; Ai C; Bai M; Niu J; Zhang Z Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142531 [TBL] [Abstract][Full Text] [Related]
6. The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications. Ding K; Song C; Hu H; Yin K; Huang H; Tang H Oxid Med Cell Longev; 2022; 2022():3790721. PubMed ID: 36111168 [TBL] [Abstract][Full Text] [Related]
7. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway. Li X; Li Z; Li B; Zhu X; Lai X Life Sci; 2019 Oct; 234():116773. PubMed ID: 31422095 [TBL] [Abstract][Full Text] [Related]
8. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline. Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530 [TBL] [Abstract][Full Text] [Related]
9. Puerarin inhibits hyperglycemia-induced inter-endothelial junction through suppressing endothelial Nlrp3 inflammasome activation via ROS-dependent oxidative pathway. Lian D; Yuan H; Yin X; Wu Y; He R; Huang Y; Chen Y Phytomedicine; 2019 Mar; 55():310-319. PubMed ID: 30385134 [TBL] [Abstract][Full Text] [Related]
10. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome. Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway. Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010 [TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171 [TBL] [Abstract][Full Text] [Related]
13. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice. Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377 [TBL] [Abstract][Full Text] [Related]
14. Taohuajing reduces oxidative stress and inflammation in diabetic cardiomyopathy through the sirtuin 1/nucleotide-binding oligomerization domain-like receptor protein 3 pathway. Yao R; Cao Y; Wang C; Xu L; Zhang X; Deng Y; Li F; Wang S BMC Complement Med Ther; 2021 Feb; 21(1):78. PubMed ID: 33637069 [TBL] [Abstract][Full Text] [Related]
15. Taurine Alleviates Schistosoma-Induced Liver Injury by Inhibiting the TXNIP/NLRP3 Inflammasome Signal Pathway and Pyroptosis. Liu X; Zhang YR; Cai C; Ni XQ; Zhu Q; Ren JL; Chen Y; Zhang LS; Xue CD; Zhao J; Qi YF; Yu YR Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570558 [TBL] [Abstract][Full Text] [Related]
16. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction. Lei Q; Yi T; Chen C Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099 [TBL] [Abstract][Full Text] [Related]
17. Chemerin/CMKLR1 Axis Promotes Inflammation and Pyroptosis by Activating NLRP3 Inflammasome in Diabetic Cardiomyopathy Rat. Xie Y; Huang Y; Ling X; Qin H; Wang M; Luo B Front Physiol; 2020; 11():381. PubMed ID: 32390873 [TBL] [Abstract][Full Text] [Related]
18. [Molecular regulative mechanisms of NLRP3 inflammasome activation in diabetic nephropathy and interventional effects of Chinese herbal medicine]. Wang WW; Han WB; Wan YG; Tu Y; Liu BH; Liu YL; Wu W; Yee HY; Fang QJ; Yao J Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):7-13. PubMed ID: 32237405 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia potentiates LPS-induced inflammatory response and increases cell death by promoting NLRP3 inflammasome activation in pancreatic β cells. Chen C; Ma X; Yang C; Nie W; Zhang J; Li H; Rong P; Yi S; Wang W Biochem Biophys Res Commun; 2018 Jan; 495(4):2512-2518. PubMed ID: 29278702 [TBL] [Abstract][Full Text] [Related]
20. Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis Mai W; Xu Y; Xu J; Zhao D; Ye L; Yu G; Wang Z; Lu Q; Lin J; Yang T; Gu C; Liu S; Zhong Y; Yang H Front Pharmacol; 2020; 11():185. PubMed ID: 32194416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]